Takeda's Licensing Activities

Takeda's mission is to "strive towards better health for patients worldwide through leading innovation in medicine." To deliver innovative new drugs longed for by patients, doctors, and healthcare professionals as early as possible, Takeda positions its alliance and licensing as reinforcement for its proprietary research and development pipelines. To develop global licensing activities dynamically, Takeda established a system that enables quick action and decision-making through alliance specialists in the United States, Europe, and Asia, in addition to Japan.

Takeda also maintains the followings as the basic concepts of its licensing activities to maximize the synergy from combinations of our superior points with those of our partner.

• 1. Respecting our partner's passion and visions.
• 2. Proposing a creative “win-win” scheme that will generate merits for both Takeda and our partner.
• 3. Dedication and commitment  by a team of involved divisions and top management, leading to a successful alliance.

In this homepage, licensing activities of our company are described by itemizing them as follows.

1. Takeda as a world-class partner

The Takeda Group, which sells its four original international strategic products^[*] in major countries, is appreciated as a global alliance partner. Takeda cherishes its relationships of mutual trust with its partners and develops their ideas and/or compounds into global products by taking advantage of our original research and development and sales capabilities.

[*] Leuplin (generic name: leuprorelin acetate), a treatment for prostate cancer and endometriosis; Takepron (generic name: lansoprazole), a treatment for peptic ulcer; Blopress (generic name: candesartan cilexetil), an anti-hypertensive agent; and Actos (generic name: pioglitazone hydrochloride), an antidiabetic agent.

2. Therapeutic and Technology Areas sought by Takeda

We describe the therapeutic areas that Takeda places priority on, under the background of our wealth of knowledge and expertise, together with a challenging therapeutic area, into which Takeda plans to explore with joining the new market. It is also aggressively exploring unique drug-development technologies.

3. Recent achievement deals

This section describes the records of Takeda's successful alliances with various partners, global or domestic pharmaceutical companies or biotech companies.

4. The Process

Takeda follows our alliance processes from the first contact to fulfillment of the contract in a steady way, but with speedy steps.

5. Out Licensing / Partnering

Takeda may also conduct the development and sales of our original compounds with partners with excellent know-how to deliver them to the world as early as possible.

6. Licensing Proposal

Inquiries about our licensing activities and information on ideas and compounds are accepted here.